Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H6N2O2 |
Molecular Weight | 174.1561 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(C=CC=C1N=C=O)N=C=O
InChI
InChIKey=RUELTTOHQODFPA-UHFFFAOYSA-N
InChI=1S/C9H6N2O2/c1-7-8(10-5-12)3-2-4-9(7)11-6-13/h2-4H,1H3
Molecular Formula | C9H6N2O2 |
Molecular Weight | 174.1561 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Immunologic cross-reactivity between different albumin-bound isocyanates. | 1983 Feb |
|
In vivo and in vitro reactions of toluene diisocyanate isomers with guinea pig hemoglobin. | 1996 Apr-May |
|
Albumin adducts in plasma from workers exposed to toluene diisocyanate. | 1997 Feb |
|
Toluene diisocyanate enhances substance P in sensory neurons innervating the nasal mucosa. | 2000 Feb |
|
A comparative respiratory sensitization study of 2,4- and 2,6-toluene diisocyanate using guinea pigs. | 2000 Jul |
|
Exposure to 2,4- and 2,6-toluene diisocyanate (TDI) during production of flexible foam: determination of airborne TDI and urinary 2,4- and 2,6-toluenediamine (TDA). | 2001 Jul |
|
Azo-containing urethane analogues for colonic drug delivery: synthesis, characterization and in-vitro evaluation. | 2001 Jun |
|
Identification of mammary carcinogens in rodent bioassays. | 2002 |
|
LC-MS determination of urinary toluenediamine in workers exposed to toluenediisocyanate. | 2002 Aug 5 |
|
Organic analysis by ion chromatography. 1. Determination of aromatic amines and aromatic diisocyanates by cation-exchange chromatography with amperometric detection. | 2002 May 17 |
|
Role of tumor necrosis factor in toluene diisocyanate asthma. | 2002 Oct |
|
Exposure and nasal inflammation in workers heating polyurethane. | 2002 Sep |
|
Determination of unreacted 2,4-toluene diisocyanate (2,4TDI) and 2,6-toluene diisocyanate (2,6TDI) in foams at ultratrace level by using HPLC-CIS-MS-MS. | 2003 Dec |
|
Development, validation and characterization of an analytical method for the quantification of hydrolysable urinary metabolites and plasma protein adducts of 2,4- and 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate. | 2003 May-Aug |
|
MMNTP-a new tailor-made modular derivatization agent for the selective determination of isocyanates and diisocyanates. | 2004 Apr |
|
Ferrocenoyl piperazide as derivatizing agent for the analysis of isocyanates and related compounds using liquid chromatography/electrochemistry/mass spectrometry (LC/EC/MS). | 2004 Dec |
|
Determination of isocyanates in air using 1-(2-methoxyphenyl)piperazine-impregnated filters: long-term sampling performance and field comparison with impingers with dibutylamine. | 2004 Jul |
|
Upper reference limits for biomarkers of exposure to aromatic diisocyanates. | 2005 Aug |
|
Quantitative determination of hexamethylene diisocyanate (HDI), 2,4-toluene diisocyanate (2,4-TDI) and 2,6-toluene diisocyanate (2,6-TDI) monomers at ppt levels in air by alkaline adduct coordination ionspray tandem mass spectrometry. | 2005 Feb |
|
DNA strand breaks in the lymphocytes of workers exposed to diisocyanates: indications of individual differences in susceptibility after low-dose and short-term exposure. | 2005 Jun |
|
Determination of airborne isocyanates generated during the thermal degradation of car paint in body repair shops. | 2006 Jun |
|
Skin exposure to isocyanates: reasons for concern. | 2007 Mar |
|
Active single-drop microextraction for the determination of gaseous diisocyanates. | 2008 Mar 28 |
|
Quantum chemistry studies of far-infrared spectra of aromatic urethanes. | 2008 Nov 1 |
|
Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins. | 2010 Aug |
|
Dermal uptake and excretion of 14C-toluene diisocyante (TDI) and 14C-methylene diphenyl diisocyanate (MDI) in male rats. Clinical signs and histopathology following dermal exposure of male rats to TDI. | 2010 Dec 15 |
|
The GSTP1 Ile105 Val polymorphism modifies the metabolism of toluene di-isocyanate. | 2010 Feb |
|
A new general pathway for synthesis of reference compounds of N-terminal valine-isocyanate adducts. | 2010 Mar 15 |
|
Removal of parabens from aqueous solution using β-cyclodextrin cross-linked polymer. | 2010 Sep 20 |
|
Production, characterization and utility of a panel of monoclonal antibodies for the detection of toluene diisocyanate haptenated proteins. | 2011 Oct 28 |
|
Exocrine pancreatic carcinogenesis and autotaxin expression. | 2012 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:11:52 GMT 2023
by
admin
on
Fri Dec 15 15:11:52 GMT 2023
|
Record UNII |
78243HXH5O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
53557
Created by
admin on Fri Dec 15 15:11:52 GMT 2023 , Edited by admin on Fri Dec 15 15:11:52 GMT 2023
|
PRIMARY | |||
|
7040
Created by
admin on Fri Dec 15 15:11:52 GMT 2023 , Edited by admin on Fri Dec 15 15:11:52 GMT 2023
|
PRIMARY | |||
|
91-08-7
Created by
admin on Fri Dec 15 15:11:52 GMT 2023 , Edited by admin on Fri Dec 15 15:11:52 GMT 2023
|
PRIMARY | |||
|
202-039-0
Created by
admin on Fri Dec 15 15:11:52 GMT 2023 , Edited by admin on Fri Dec 15 15:11:52 GMT 2023
|
PRIMARY | |||
|
78243HXH5O
Created by
admin on Fri Dec 15 15:11:52 GMT 2023 , Edited by admin on Fri Dec 15 15:11:52 GMT 2023
|
PRIMARY | |||
|
DTXSID2026157
Created by
admin on Fri Dec 15 15:11:52 GMT 2023 , Edited by admin on Fri Dec 15 15:11:52 GMT 2023
|
PRIMARY | |||
|
5272
Created by
admin on Fri Dec 15 15:11:52 GMT 2023 , Edited by admin on Fri Dec 15 15:11:52 GMT 2023
|
PRIMARY |